Analyst Ratings for Alnylam Pharmaceuticals (ALNY)
ALNY Rating Summary
ALNY Price Target Summary
- Highest: $580.00 (Goldman Sachs)
- Lowest: $343.00 (Leerink Partners)
- Average: $465.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$465.00 (+45%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/17/2026 | Freedom Capital Markets | Ilya Zubkov | Upgrade | Buy (Hold) |
410.00 (470.00) |
314.40 (320.66) |
1.99% | Details |
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
527.00 (N/A) |
361.35 (320.66) |
-11.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
